![High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients With Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696]()
High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients With Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696Kirkwood, John M.; Ibrahim, Joseph; Lawson, David H.; Atkins, Michael B.; Agarwala, Sanjiv S.; Collins, Keirsten; Mascari, Ruth; Morrissey, Donna M.; Chapman, Paul B. · Journal of Clinical Oncology · 2001